郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery.

期刊：Journal of the American Chemical Society发表年份：2009作者：Juewen Liu; Xingmao Jiang; Carlee Ashley; C Jeffrey Brinker
阅读更多 →

药效评价Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonists.

期刊：Journal of medicinal chemistry发表年份：2009作者：Dahui Zhou; Gary P Stack; Jennifer Lo; Amedeo A Failli; Deborah A Evrard; Boyd L Harrison; Nicole T Hatzenbuhler; Megan Tran; Susan Croce; Soo Yi; Jeannette Golembieski; Geoffrey A Hornby; Margaret Lai; Qian Lin; Lee E Schechter; Deborah L Smith; Ada
阅读更多 →

药效评价Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits.

期刊：Journal of medicinal chemistry发表年份：2009作者：Edward C Lawson; Diane K Luci; Shyamali Ghosh; William A Kinney; Charles H Reynolds; Jenson Qi; Charles E Smith; Yuanping Wang; Lisa K Minor; Barbara J Haertlein; Tom J Parry; Bruce P Damiano; Bruce E Maryanoff
阅读更多 →

药效评价Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands.

期刊：BMC pharmacology发表年份：2009作者：Christopher N Davis; Stefania Risso Bradley; Hans H Schiffer; Mikael Friberg; Kristian Koch; Bo-Ragnar Tolf; Douglas W Bonhaus; Jelveh Lameh
阅读更多 →